13D/13G Filings - Innate Pharma SA (IPHA)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-12-06
11:52 am
Sale
2022-11-23 13D Innate Pharma S.A.
IPHA
Bpifrance Participations S.A. 7,186,628
9.000%
-801,741decrease
(-10.04%)
Filing
History
2022-10-21
12:58 pm
Sale
2022-10-11 13D Innate Pharma S.A.
IPHA
Bpifrance Participations S.A. 7,988,369
10.000%
-964,098decrease
(-10.77%)
Filing
History
2021-02-12
2:35 pm
Purchase
2021-02-12 13D Innate Pharma S.A.
IPHA
Bpifrance Participations S.A. 8,952,467
11.300%
8,952,467increase
(New Position)
Filing
History